Works matching AU Ahn, Jin Hee


Results: 176
    1
    2

    Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.

    Published in:
    2015
    By:
    • Yoon Ji Choi;
    • Dae Ho Lee;
    • Chang Min Choi;
    • Jung Shin Lee;
    • Seung Jin Lee;
    • Jin-Hee Ahn;
    • Sang-We Kim;
    • Choi, Yoon Ji;
    • Lee, Dae Ho;
    • Choi, Chang Min;
    • Lee, Jung Shin;
    • Lee, Seung Jin;
    • Ahn, Jin-Hee;
    • Kim, Sang-We
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 523, doi. 10.4143/crt.2022.1360
    By:
    • Dae-Won Lee;
    • Bhumsuk Keam;
    • Keun Seok Lee;
    • Jin-Hee Ahn;
    • Joohyuk Sohn;
    • Jin Seok Ahn;
    • Moon Hee Lee;
    • Jee Hyun Kim;
    • Kyung Eun Lee;
    • Hyo Jung Kim;
    • Si-Young Kim;
    • Yeon Hee Park;
    • Chan-Young Ock;
    • Kyung-Hun Lee;
    • Sae-Won Han;
    • Sung-Bae Kim;
    • Young Hyuck Im;
    • Hyun Cheol Chung;
    • Do-Youn Oh;
    • Seock-Ah Im
    Publication type:
    Article
    12
    13
    14
    15

    Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 1, p. 43, doi. 10.4143/crt.2017.562
    By:
    • In Hae Park;
    • Seock-Ah Im;
    • Kyung Hae Jung;
    • Joo Hyuk Sohn;
    • Yeon Hee Park;
    • Keun Seok Lee;
    • Sung Hoon Sim;
    • Kyong-Hwa Park;
    • Jee Hyun Kim;
    • Byung Ho Nam;
    • Hee-Jun Kim;
    • Tae-Yong Kim;
    • Kyung-Hun Lee;
    • Sung-Bae Kim;
    • Jin-Hee Ahn;
    • Suee Lee;
    • Jungsil Ro
    Publication type:
    Article
    16

    Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1373, doi. 10.4143/crt.2015.475
    By:
    • Se Hyun Kim;
    • Kyung Hae Jung;
    • Tae-Yong Kim;
    • Seock-Ah Im;
    • In Sil Choi;
    • Yee Soo Chae;
    • Sun Kyung Baek;
    • Seok Yun Kang;
    • Sarah Park;
    • In Hae Park;
    • Keun Seok Lee;
    • Yoon Ji Choi;
    • Soohyeon Lee;
    • Joo Hyuk Sohn;
    • Yeon-Hee Park;
    • Young-Hyuck Im;
    • Jin-Hee Ahn;
    • Sung-Bae Kim;
    • Jee Hyun Kim
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    A Randomized Feasibility Study of <sup>18</sup>F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, n. 4, p. 563, doi. 10.2967/jnumed.116.178368
    By:
    • Sun Young Chae;
    • Sung-Bae Kim;
    • Sei Hyun Ahn;
    • Hye Ok Kim;
    • Dok Hyun Yoon;
    • Jin-Hee Ahn;
    • Kyung Hae Jung;
    • Sangwon Han;
    • Seung Jun Oh;
    • Sang Ju Lee;
    • Hee Jeong Kim;
    • Byung Ho Son;
    • Gyungyub Gong;
    • Hyo Sang Lee;
    • Dae Hyuk Moon
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70887-5
    By:
    • Yoo, Tae-Kyung Robyn;
    • Lee, Ji-Young;
    • Park, Hwan;
    • Cho, Whi-Kyung;
    • Jeon, Seyeon;
    • Jun, Ha Ra;
    • Lee, Sae Byul;
    • Chung, Il Yong;
    • Kim, Hee Jeong;
    • Ko, Beom Seok;
    • Lee, Jong Won;
    • Son, Byung Ho;
    • Ahn, Sei-Hyun;
    • Jeong, Jae Ho;
    • Kim, Jeong Eun;
    • Ahn, Jin-Hee;
    • Jung, Kyung Hae;
    • Kim, Sung-Bae;
    • Lee, Hee Jin;
    • Gong, Gyungyub
    Publication type:
    Article
    36

    Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI

    Published in:
    Medical Oncology, 2012, v. 29, n. 5, p. 3291, doi. 10.1007/s12032-012-0227-7
    By:
    • Park, Kwonoh;
    • Lee, Jae-Lyun;
    • Park, Inkeun;
    • Park, Seongjoon;
    • Ahn, Yongcheol;
    • Ahn, Jin-Hee;
    • Ahn, Shin;
    • Song, Cheryn;
    • Hong, Jun;
    • Kim, Choung-Soo;
    • Ahn, Hanjong
    Publication type:
    Article
    37
    38
    39
    40

    Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers.

    Published in:
    2016
    By:
    • Park, Ji;
    • Kang, Myung;
    • Ahn, Jin-Hee;
    • Kim, Jeong;
    • Jung, Kyung;
    • Gong, Gyungyub;
    • Lee, Hee;
    • Son, Byung-Ho;
    • Ahn, Sei-Hyun;
    • Kim, Hak-Hee;
    • Shin, Hee;
    • Moon, Dae-Hyuk;
    • Kim, Sung-Bae;
    • Park, Ji Hyun;
    • Kang, Myung Joo;
    • Kim, Jeong Eun;
    • Jung, Kyung Hae;
    • Lee, Hee Jin;
    • Shin, Hee Jung
    Publication type:
    journal article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50